Ketamine Clinical Trials
Conditions / Ketamine
Delta Trials records 63 clinical trials for Ketamine in its publicly accessible dataset. From the full dataset, 9 actively seeking eligible participants and 35 trials have reached completion. This research is conducted across 46 study locations around the world. An additional 19 trials are active but not currently open for enrollment. Since 2020, 3 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
63
Total Trials
9
Recruiting
35
Completed
19
Other Active
3
Terminated since 2020
46
Study Locations
Browse by location (46 total)
- Athens, Greece 7 trialsAll trials in Athens, Greece
- Athens, Greece 7 trialsAll trials in Athens, Greece
- Beijing, China 5 trialsAll trials in Beijing, China
- Cairo, Egypt 5 trialsAll trials in Cairo, Egypt
- Nanjing, China 5 trialsAll trials in Nanjing, China
- Tanta, Egypt 4 trialsAll trials in Tanta, Egypt
- Changsha, China 3 trialsAll trials in Changsha, China
- Saskatoon, Canada 3 trialsAll trials in Saskatoon, Canada
- Bethesda, United States 3 trialsAll trials in Bethesda, United States
- Brooklyn, United States 2 trialsAll trials in Brooklyn, United States
- Huaian, China 2 trialsAll trials in Huaian, China
- Hangzhou, China 2 trialsAll trials in Hangzhou, China
- Kuala Lumpur, Malaysia 2 trialsAll trials in Kuala Lumpur, Malaysia
- Treviso, Italy 2 trialsAll trials in Treviso, Italy
- Vancouver, Canada 1 trialAll trials in Vancouver, Canada
- Yangsan, South Korea 1 trialAll trials in Yangsan, South Korea
- Develi, Turkey (türkiye) 1 trialAll trials in Develi, Turkey (türkiye)
- Baltimore, United States 1 trialAll trials in Baltimore, United States
- İstanbul, Turkey (türkiye) 1 trialAll trials in İstanbul, Turkey (türkiye)
- Istanbul, Turkey (türkiye) 1 trialAll trials in Istanbul, Turkey (türkiye)